Literature DB >> 7764072

High level, stable production of recombinant proteins in mammalian cell culture using the herpesvirus VP16 transactivator.

P Hippenmeyer1, M Highkin.   

Abstract

We have engineered mammalian cell lines to produce high levels of heterologous proteins by constructing a cell line that expresses the herpesvirus transactivator, VP16. Subsequent stable transfection with a gene of interest under control of a herpesvirus immediate early promoter led to a rapid isolation of cell lines producing between 1 and 20 micrograms of protein/million cells/24 hours. This high level expression is stable for at least five months.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764072     DOI: 10.1038/nbt0993-1037

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  10 in total

1.  Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites.

Authors:  Søren Ottosen; Francisco J Herrera; James R Doroghazi; Angela Hull; Sheenu Mittal; William S Lane; Steven J Triezenberg
Journal:  Virology       Date:  2005-11-17       Impact factor: 3.616

2.  Expression of the truncated tissue plasminogen activator (K2S) gene in tobacco chloroplast.

Authors:  Maryam Abdoli-Nasab; Mokhtar Jalali-Javaran; Rosa M Cusidó; Javier Palazón; Amin Baghizadeh; Houshang Alizadeh
Journal:  Mol Biol Rep       Date:  2013-10-11       Impact factor: 2.316

3.  Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein.

Authors:  D T Connolly; J McIntyre; D Heuvelman; E E Remsen; R E McKinnie; L Vu; M Melton; R Monsell; E S Krul; K Glenn
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.

Authors:  D B Knoerzer; R W Karr; B D Schwartz; L J Mengle-Gaw
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

5.  Molecular cloning and expression of human leukotriene-C4 synthase.

Authors:  D J Welsch; D P Creely; S D Hauser; K J Mathis; G G Krivi; P C Isakson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

6.  Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

Authors:  A H Cross; T J Girard; K S Giacoletto; R J Evans; R M Keeling; R F Lin; J L Trotter; R W Karr
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

Authors:  J W Thomas; C M Baum; W F Hood; B Klein; J B Monahan; K Paik; N Staten; M Abrams; J P McKearn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Engineering of chaperone systems and of the unfolded protein response.

Authors:  Saeed U Khan; Martin Schröder
Journal:  Cytotechnology       Date:  2008-08-15       Impact factor: 2.058

9.  Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium.

Authors:  Kanagasabai Vadivel; Amy E Schmidt; Duilio Cascio; Kaillathe Padmanabhan; Sriram Krishnaswamy; Hans Brandstetter; S Paul Bajaj
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-05-14       Impact factor: 5.699

10.  Genetic control of natural killing and in vivo tumor elimination by the Chok locus.

Authors:  A H Idris; K Iizuka; H R Smith; A A Scalzo; W M Yokoyama
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.